Peppies Peppies tortoise mark

Plain answers

Peptides & the FDA review: your questions, answered

The questions people actually ask - answered in plain English, with links to check the facts yourself. Nothing here is medical advice.

Select a topic category to narrow down questions.

When will the FDA review PEG-MGF?

Not on the July 2026 agenda. A later review is anticipated (reported as early 2027); no official FDA date was confirmed as of July 2026.1 2

What is MGF versus PEG-MGF?

MGF (mechano growth factor) is a natural splice variant of IGF-1 that muscle makes locally after loading or injury. PEG-MGF is a synthetic, pegylated version of the MGF E-domain peptide designed to last longer.3 4

Is PEG-MGF legal in the United States in 2026?

PEG-MGF is not an FDA-approved drug and has no cleared compounding pathway. It was removed from Category 2 in April 2026 but is not on the July 2026 agenda; a later review is expected.2 1

Does exercise really raise MOTS-c?

Some human studies report that MOTS-c levels increase with exercise, and that lower levels correlate with obesity and higher fasting insulin. These are associations from observational research, not proof that supplementing MOTS-c produces a health benefit.5

What was MOTS-c evaluated for at the July 2026 meeting?

The FDA-evaluated uses listed for MOTS-c are obesity and osteoporosis.6

Is MOTS-c legal in the United States in 2026?

MOTS-c is not an FDA-approved drug and has no cleared compounding pathway. It was in Category 2 of the interim 503A list, then removed in April 2026 and referred to the July 2026 advisory committee. Removal did not place it on the approved list.6 7 8

When will the FDA review Melanotan II?

Not on the July 2026 agenda. A later review is anticipated (reported as early 2027); no official FDA date was confirmed as of July 2026.54

Is Melanotan II dangerous?

Published case reports and reviews document serious adverse events, including rhabdomyolysis, kidney injury, cardiovascular effects, and priapism, and the FDA has warned against unapproved tanning injections. No controlled trial has established a safe dose.123

Is Melanotan II legal in the United States in 2026?

Melanotan II is not FDA-approved and has no cleared compounding pathway. It was removed from Category 2 in April 2026 but is not on the July 2026 agenda; a later review is expected. The FDA has warned consumers against unapproved tanning injections.453

When will the FDA review LL-37?

It wasn't on the July 2026 agenda. Analysts of the April 2026 action expect the remaining peptides to be reviewed at a later meeting (reported as early 2027); no official FDA notice had confirmed a date as of July 2026.9 10

Get notified

Be ready the moment the comment window opens

The vote is advisory. The decision that shapes access comes later - if and when the FDA opens a formal public comment window. Most people never hear it opened. Join the list and we'll tell you the instant it does, with step-by-step instructions to file a comment that counts.

Get notified →